Control of alternative splicing of potassium channels by stress hormones

Science

Volumn 280, Issue 5362, 1998, Pages 443-446

  Xie, Jiuyong ^a   McCobb, David P ^a  

^a Department of Population Medicine and Diagnostic Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; MEMBRANE PROTEIN; PHENYLETHANOLAMINE N METHYLTRANSFERASE; POTASSIUM CHANNEL; SLO PROTEIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHROMAFFIN CELL; CONTROLLED STUDY; HYPOPHYSECTOMY; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RAT; XENOPUS;

ADRENAL MEDULLA; ADRENOCORTICOTROPIC HORMONE; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; CHROMAFFIN CELLS; CORTICOSTERONE; DEXAMETHASONE; EPINEPHRINE; EXONS; FEMALE; HYPOPHYSECTOMY; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MALE; MOLECULAR SEQUENCE DATA; OOCYTES; PHENYLETHANOLAMINE N-METHYLTRANSFERASE; POLYMERASE CHAIN REACTION; POTASSIUM CHANNELS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; XENOPUS;

ANIMALIA;

EID: 0032540395     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.280.5362.443     Document Type: Article

References (34)

1. M. E. Ross et al., J. Neurosci. 10, 520 (1990); S. N. Ebert et al., J. Biol. Chem. 269, 20885 (1994).
2. M. E. Ross et al., J. Neurosci. 10, 520 (1990); S. N. Ebert et al., J. Biol. Chem. 269, 20885 (1994).
3. E. S. Levitan, K. M. Hershman, T. G. Sherman, K. Takimoto, Neuropharmacology 35, 1001 (1996); K. Takimoto and E. S. Levitan, Circ. Res. 75, 1 (1994); K. Takimoto, A. F. Fomina, R. Gealy, J. S. Trimmer, E. S. Levitan, Neuron 11, 359 (1993); B. Attardi, K. Takimoto, R. Gealy, C. Severns, E. S. Levitan, Receptors Channels 1, 287 (1993).
4. E. S. Levitan, K. M. Hershman, T. G. Sherman, K. Takimoto, Neuropharmacology 35, 1001 (1996); K. Takimoto and E. S. Levitan, Circ. Res. 75, 1 (1994); K. Takimoto, A. F. Fomina, R. Gealy, J. S. Trimmer, E. S. Levitan, Neuron 11, 359 (1993); B. Attardi, K. Takimoto, R. Gealy, C. Severns, E. S. Levitan, Receptors Channels 1, 287 (1993).
5. E. S. Levitan, K. M. Hershman, T. G. Sherman, K. Takimoto, Neuropharmacology 35, 1001 (1996); K. Takimoto and E. S. Levitan, Circ. Res. 75, 1 (1994); K. Takimoto, A. F. Fomina, R. Gealy, J. S. Trimmer, E. S. Levitan, Neuron 11, 359 (1993); B. Attardi, K. Takimoto, R. Gealy, C. Severns, E. S. Levitan, Receptors Channels 1, 287 (1993).
6. E. S. Levitan, K. M. Hershman, T. G. Sherman, K. Takimoto, Neuropharmacology 35, 1001 (1996); K. Takimoto and E. S. Levitan, Circ. Res. 75, 1 (1994); K. Takimoto, A. F. Fomina, R. Gealy, J. S. Trimmer, E. S. Levitan, Neuron 11, 359 (1993); B. Attardi, K. Takimoto, R. Gealy, C. Severns, E. S. Levitan, Receptors Channels 1, 287 (1993).
7. C. R. Solaro, M. Prakriya, J. P. Ding, C. J. Lingle, J. Neurosci. 15, 6110 (1995).
8. C. J. Lingle, C. R. Solaro, M. Prakriya, J. P. Ding, Ion Channels 4, 261 (1996).
9. A. Butler, S. Tsunoda, D. P. McCobb, A. Wei, L. Salkoff, Science 261, 221 (1993); J. Tseng-Crank et al., Neuron 13, 1315 (1994).
10. A. Butler, S. Tsunoda, D. P. McCobb, A. Wei, L. Salkoff, Science 261, 221 (1993); J. Tseng-Crank et al., Neuron 13, 1315 (1994).
11. J. P. Adelman et al., Neuron 9, 209 (1992); N. S. Atkinson, G. A. Robertson, B. Ganetzky, Science 253, 551 (1991).
12. J. P. Adelman et al., Neuron 9, 209 (1992); N. S. Atkinson, G. A. Robertson, B. Ganetzky, Science 253, 551 (1991).
13. M. K. Stachowiak, R. J. Rigual, P. H. K. Lee, O. H. Viveros, J. S. Hong, Mol. Brain Res. 3, 275 (1988); E. Viskupic et al., J. Neurochem. 63, 808 (1994).
14. M. K. Stachowiak, R. J. Rigual, P. H. K. Lee, O. H. Viveros, J. S. Hong, Mol. Brain Res. 3, 275 (1988); E. Viskupic et al., J. Neurochem. 63, 808 (1994).
15. J. Xie, P. Lappas, W. Yao, E. Carpenter-Hyland, D. P. McCobb, Soc. Neurosci. Abstr. 22, 402 (1996). For calibrated RT-PCR, different amounts of calibrator template cRNA {constructed as per S. Diviacco et al. [Gene 122, 313 (1992)]} were added to identical 12.5-ng samples of tissue RNA. Relative PCR product band intensity was measured with BIT Image 1.55 (Digital Imagers, Elburn, IL). We measured the native template by extrapolating to the calibrator template amount yielding equivalent product bands, with corrections for length effects on amplification efficiency and band intensity.
16. J. Xie, P. Lappas, W. Yao, E. Carpenter-Hyland, D. P. McCobb, Soc. Neurosci. Abstr. 22, 402 (1996). For calibrated RT-PCR, different amounts of calibrator template cRNA {constructed as per S. Diviacco et al. [Gene 122, 313 (1992)]} were added to identical 12.5-ng samples of tissue RNA. Relative PCR product band intensity was measured with BIT Image 1.55 (Digital Imagers, Elburn, IL). We measured the native template by extrapolating to the calibrator template amount yielding equivalent product bands, with corrections for length effects on amplification efficiency and band intensity.
17. Sprague-Dawley rats (Charles River) were hypophy-sectomized with the parapharyngeal approach to the occipitosphenoid suture. After trephination, the hypophysis was removed by aspiration. Hypophysectomized rats received 5% sucrose water. Marked reductions in adrenal cortical volume and rat body weight at death, compared with age- and sex-matched rats, indicated successful hypophysectomy.
18. M. Saito, C. Nelson, L. Salkoff, C. J. Lingle, J. Biol. Chem. 272, 11710 (1997).
19. J. Ferrer, J. Wasson, L. Salkoff, M. A. Permutt, Diabetologia 39, 891 (1996).
20. 22 (Gibco BRL). One microliter of RT product was used in a 25-μl PCR for 30 cycles at 94°C, 30-s denaturation; 55°C. 30-s annealing; and 72°C, 30-s extension. Five microliters of product was run on a 2% agarose gel stained with ethidium bromide.
21. ACTH was in gel form (Rhone Poulenc Rorer Pharmaceutical, Collegeville, PA).
22. R. E. Coupland, The Natural History of the Chromaffin Cell (Longmans, London, 1965); R. J. Wurtman and J. Axelrod, J. Biol. Chem. 241, 2301 (1966).
23. R. E. Coupland, The Natural History of the Chromaffin Cell (Longmans, London, 1965); R. J. Wurtman and J. Axelrod, J. Biol. Chem. 241, 2301 (1966).
24. IMMUCHEM Double Antibody Corticosterone RIA kit (ICN, Irvine, CA) was used by the veterinary diagnostic lab at Cornell University. Corticosterone was extracted from ground adrenals with 0.5 ml of ethyl acetate at room temperature and spun at 11,000 rpm for 5 min, and the upper phase was saved, vacuum dried, and resuspended in 400 μl of resuspension buffer with 5% ethanol.
25. Plasmid constructs for cRNA expression in Xenopus oocytes were devised by modification of a mouse Slo (mSlo) expression construct (5). Rat adrenal RT-PCR products corresponding to ZERO, STREX-1, and STREX-2 variants were made with primers rSlo3 and a downstream primer with ah internal Xho I site (sequence: 5′-ACCGCTCGAGCTCTGGCGTGGCTCCTCCTG-3′) and cloned into unique Hind III and Xho I sites in the mSlo vector. Restriction analysis and sequencing were used to confirm constructs. mSlo differs from rSlo outside the rat insert at only 4 of 716 residues. Rasmids were linearized with Sal I and transcribed with Ambion T3 mMESSAGE kit.
26. Patch clamp solutions were potassium methanesulfonate based (pH 7.0). Free calcium concentrations were determined with a calcium-selective electrode (Orion, Beverly, MA). Procedure and solutions were as described by D. P. McCobb et al. [Am. J. Physiol. 269, H767 (1995)]. A List EPC-7 patch clamp with ITC-16 data interface (Instrutech, NY) and Pulse software (HEKA, Lambrecht, Germany) were used for data acquisition.
27. D. P. McCobb, J. Xie, D. Baro, Soc. Neurosci. Abstr. 23, 1477 (1997).
28. S. Ceccatelli, A. Dagerlind, M. Schalling, A.-C. Wikstorm, Acta Physiol. Scand. 137, 559 (1989).
29. D. L. Wong, A. Lesage, B. Siddall, J. W. Funder, FASEB J. 6, 3310 (1992); D. L. Wong, R. J. Hayashi, R. D. Ciaranello, Brain Res. 330, 209 (1985).
30. D. L. Wong, A. Lesage, B. Siddall, J. W. Funder, FASEB J. 6, 3310 (1992); D. L. Wong, R. J. Hayashi, R. D. Ciaranello, Brain Res. 330, 209 (1985).
31. G. G. Nussdorfer, Pharmacol. Rev. 48, 495 (1996).
32. R. C. Lake and M. G. Ziegler, The Catecholamines in Psychiatric and Neurologic Disorders (Butterworth, Stoneham, MA, 1985).
33. J. E. Kraus, J. V. Nadler, J. O. McNamara, Mol. Brain Res. 41, 97 (1996).
34. We thank R. Harris-Warrick, D. Baro, R. Knapp, A. Bass, and R. Hoy for helpful discussions. Supported by the American Heart Association.